TABLE 2 The Positive Rates of 4 Mucins and 7 Cytokeratins in Digestive Cancers

From: Expression of Mucins and Cytokeratins in Primary Carcinomas of the Digestive System

Organ

MUC1

MUC2

MUC5AC

MUC6

CK7

CK8

CK13

CK14

CK18

CK19

CK20

Stomach

17/55 (30.9%)

17/55 (30.9%)

31/55 (56.4%)

19/55 (34.5%)

41/55 (74.5%)

52/55 (94.5%)

52/55 (94.5%)

1/55 (1.8%)

54/55 (98.2%)

46/55 (83.6%)

17/55 (30.9%)

Liver (hepatocyte)

1/60 (1.7%)

2/60 (3.3%)

0/60 (0%)

1/60 (1.7%)

9/60 (15.0%)

30/60 (50%)

1/60 (1.7%)

0/60 (0%)

59/60 (98.3%)

5/60 (8.3%)

0/60 (0%)

Intrahepatic bile duct

22/50 (44%)

4/50 (8.0%)

22/50 (44.0%)

7/50 (14.0%)

40/50 (80.0%)

49/50 (98%)

48/50 (96%)

0/50 (0%)

49/50 (98.0%)

48/50 (96.0%)

14/50 (28.0%)

Gall bladder

40/57 (70.2%)

4/59 (6.8%)

15/59 (25.4%)

14/59 (23.7%)

48/59 (81.4%)

52/59 (88.1%)

49/59 (83.1%)

3/59 (5.1%)

53/58 (91.4%)

42/57 (73.7%)

10/59 (16.9%)

Extrahepatic bile duct

26/40 (65.0%)

7/40 (17.5%)

24/40 (60.0%)

12/40 (30.0%)

40/40 (100%)

39/40 (97.5%)

40/40 (100%)

2/40 (5%)

39/40 (97.5%)

40/40 (100%)

12/40 (30.0%)

Pancreas

47/54 (87.0%)

5/54 (9.3%)

38/54 (70.4%)

13/54 (24.1%)

51/54 (94.4%)

54/54 (100%)

54/54 (100%)

0/54 (0%)

54/54 (100%)

54/54 (100%)

15/54 (27.8%)

Ampulla of Vater

22/38 (57.9%)

8/39 (20.5%)

11/39 (28.2%)

16/39 (41.0%)

38/39 (97.4%)

38/39 (97.4%)

38/39 (97.4%)

0/39 (0%)

39/39 (100%)

37/39 (94.9%)

17/39 (43.6%)

Small intestine

12/23 (52.2%)

10/23 (43.5%)

7/23 (30.4%)

6/23 (26.1%)

8/23 (34.8%)

23/23 (100%)

22/23 (95.7%)

0/23 (0%)

23/23 (100%)

22/23 (95.7%)

11/23 (47.8%)

Colon

23/68 (34.3%)

27/68 (39.7%)

4/68 (5.9%)

3/68 (4.4%)

7/70 (10.0%)

65/68 (95.6%)

65/68 (95.6%)

2/72 (2.7%)

61/66 (92.4%)

65/68 (95.6%)

52/68 (76.5%)

Appendix

3/18 (16.7%)

18/18 (100%)

12/18 (66.7%)

0/18 (0%)

5/18 (27.8%)

18/18 (100%)

18/18 (100%)

0/18 (0%)

18/18 (100%)

18/18 (100%)

18/18 (100%)

Anus

11/15 (73.3%)

5/15 (33.3%)

2/15 (13.3%)

2/15 (13.3%)

4/15 (26.7%)

15/15 (100%)

15/15 (100%)

4/15 (26.7%)

13/15 (86.7%)

13/15 (86.7%)

12/15 (80.0%)